Lineage Cell Therapeutics
LCTX
#8146
Rank
C$0.24 B
Marketcap
$1.24
Share price
-3.07%
Change (1 day)
-10.06%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -C$34.61 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$6.18 Million. In 2023 the company made an earning of -C$34.78 Million a decrease over its 2022 earnings that were of -C$31.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$34.61 Million-0.5%
2023 -C$34.78 Million9.83%
2022 -C$31.67 Million-54.24%
2021 -C$69.2 Million86.07%
2020 -C$37.19 Million-31.97%
2019 -C$54.67 Million-5.42%
2018 -C$57.8 Million1.1%
2017 -C$57.17 Million-31.06%
2016 -C$82.92 Million-10.38%
2015 -C$92.53 Million29.69%
2014 -C$71.35 Million31.68%
2013 -C$54.19 Million
2011 -C$26.3 Million89.78%
2010 -C$13.86 Million206.06%
2009 -C$4.53 Million-0.58%
2008 -C$4.56 Million164.89%
2007 -C$1.72 Million-30.22%
2006 -C$2.47 Million
2002 -C$2.87 Million-41.04%
2001 -C$4.86 Million-32.04%
2000 -C$7.14 Million-11.85%
1999 -C$8.1 Million
1997 -C$5.21 Million12.12%
1996 -C$4.65 Million106.25%
1995 -C$2.25 Million-11.11%
1994 -C$2.54 Million50%
1993 -C$1.69 Million20%
1992 -C$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.18 Billion 388.83%๐Ÿ‡บ๐Ÿ‡ธ USA